Increased risk of cardiovascular disease and diabetes from prolonged sitting
Related Articles

FDA Approves Zidesamtinib (Jideytro) for ROS1+ Lung Cancer
The FDA has officially approved Zidesamtinib (Jideytro) for patients with ROS1+ non-small cell lung cancer previously treated with a TKI. Learn about its clinical efficacy now.
Read moreVIET HUY NEW YEAR KICKOFF 2026: RECHARGED AND READY FOR A BREAKTHROUGH 2026
Summary of the 2026 New Year kickoff article by VIET HUY Technological Scientific Equipment Co., Ltd: Event: The Viet Huy team officially returned to work after the Tet holiday with traditional activities such as exchanging New Year wishes, handshakes, and giving lucky red envelopes. Goals for 2026: Improve the quality of services and technical solutions. Accelerate innovation and creativity in scientific & biomedical equipment. Increase sustainable value for partners and customers. Message: A spirit of unity, a determination to break through, and a drive for success in the new year's projects. Contact information: Head office in Ho Chi Minh City, representative offices in Hanoi and Da Nang, and Hotline: 0913 605 512.
Read more
CERVICAL CANCER SCREENING - THE ROLE OF HPV TESTING
Cervical cancer is a dangerous and common disease in women. However, it can be effectively prevented through screening and HPV vaccination
Read moreNeed help choosing the right testing solution?
Viet Huy engineers are ready to help your laboratory choose the optimal technology.